Apyx Medical Corporation (BOV.F)

1,2000 -0,0600 (-4,76%) Börsenschluss: 01:30PM CEST

Apyx Medical Corporation

5115 Ulmerton Road
Clearwater, FL 33760-4004
United States
727 384 2323
https://apyxmedical.com

Sektor(en): Healthcare
Branche: Medical Devices
Vollzeitmitarbeiter: 252

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Charles D. Goodwin II	President, CEO & Director	756,4k	N/A	1967
Mr. Matthew C. Hill CPA	CFO, Treasurer & Secretary	414,83k	N/A	1969
Mr. Moshe Citronowicz	Senior Vice President	377,18k	N/A	1953
Mr. Todd Hornsby	Executive Vice President	522,58k	N/A	1977

Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in EUR.

Beschreibung

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Corporate Governance

Apyx Medical Corporations ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.